drugset / Trial / NCT04065906

Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder

NCT04065906

Unknown 90 enrolled Xijing Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

To observe the clinical efficacy and mechanism of functional near-infrared spectroscopy imaging neurofeedback therapy for attention deficit and hyperactivity disorder.

Timeline

Start
2019-01-15
Primary completion
2019-12-31
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule
Subject Tomoxetine Unknown